The Past, Present and Future of COVID-19 Associated Mucormycosis: A Rapid Review

Author:

Sarfraz Zouina12ORCID,Sarfraz Azza13ORCID,Jaiswal Vikash1ORCID,Poudel Sujan1,Bano Shehar12ORCID,Hanif Muhammad1,Singh Shrestha Prakriti1,Sarfraz Muzna1,Michel George1,Cherrez-Ojeda Ivan45

Affiliation:

1. Larkin Community Hospital, South Miami, FL, USA

2. Fatima Jinnah Medical University, Lahore, Pakistan

3. The Aga Khan University, Karachi, Pakistan

4. Universidad Espíritu Santo, Samborondón, Ecuador

5. Respiralab Research Center, Guayaquil, Ecuador

Abstract

Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2, which is known for the multiple mutations and forms that have rapidly spread across the world. With the imminent challenges faced by low- and middle-income countries in curbing the public health fallbacks due to limited resources, mucormycosis emerged as a fungal infection associated with high mortality. In this rapid review, we explored MEDLINE, Cochrane, Web of Science, WHO Global Database, and the search engine—Google Scholar for articles listed until July 2021 and presented a narrative synthesis of findings from 39 articles. The epidemiology, causative factors, incidence parameters, pharmacological treatment, and recommendations for low- and middle-income countries are enlisted. This study concludes that a majority of the globally reported COVID-19 associated mucormycosis cases stemmed from India. Individuals receiving systemic corticosteroids or who have a history of diabetes mellitus are more prone to contracting the disease. Public health authorities in LMIC are recommended to strengthen antifungal therapies for COVID-19 associated mucormycosis and to strategize reduction in diabetes mellitus prevalence.

Publisher

SAGE Publications

Subject

Public Health, Environmental and Occupational Health,Community and Home Care

Reference47 articles.

1. COVID-19 infection and rheumatoid arthritis: Faraway, so close!

2. Threat Assessment Brief. Rapid increase of a SARS-CoV-2 variant with multiple spike protein mutations observed in the United Kingdom. Epidemiology. 2020.

3. Coronavirus variants are spreading in India — what scientists know so far

4. National Geographic. How India’s second wave became the worst COVID-19 surge in the world. 2021. Accessed July 16, 2021. https://www.nationalgeographic.com/science/article/how-indias-second-wave-became-the-worst-covid-19-surge-in-the-world

5. WHO Coronavirus (COVID-19) Dashboard. Covid19.who.int. 2021. Accessed May 22, 2021. https://covid19.who.int/

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3